LUTETHIUM THERAPY (up to 200 mCi)

Lutetium-177 therapy is a targeted radionuclide treatment for advanced prostate cancer available at Hisar Hospital Intercontinental in Istanbul, Turkey. A single session may cost around $8,800, with a complete package including diagnostics and consultation typically running $9,600-9,700. The hospital is JCI-accredited through 2027, and treatment is supervised by Assoc. Prof. Dr. Tamer Aksoy, a nuclear medicine specialist with _doctor_7621_years_ of experience.

About the Treatment

Lutetium-177 therapy uses radioligands that bind to PSMA receptors on prostate cancer cells. It is designed for cases resistant to other treatments. Patients usually complete 6-8 sessions spaced 8-9 weeks apart.

What's Included

• Lutetium-177 therapy per session
• Doctor consultation ($160 value)
• PET-CT Ga-68 PSMA imaging ($720)
• 1-2 nights hospitalization with meals
• Personal assistance and translation services
• Transport between airport, hotel, and clinic

Medical Team

Assoc. Prof. Dr. Tamer Aksoy leads the treatment with 900+ procedures performed. Trained at Netherlands Cancer Institute, he monitors progress using Ga-68 imaging between sessions. This allows personalized adjustments to each patient's therapy.

Hospital Features

Hisar Hospital maintains a 4.4/5 rating from 172 patients. The JCI accreditation confirms international safety standards. Multilingual staff provide support in 8 languages including English and Arabic.

Patients receive same-day ambulatory care after treatment with 1-2 nights of monitoring. The hospital can help arrange nearby accommodations for those traveling to Istanbul for therapy.